These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Predictive value of cardiac magnetic resonance imaging for adverse left ventricular remodeling after acute ST-segment elevation myocardial infarction]. Cui J, Liu W, Yan F, Zhao Y, Chen W, Luo C, Zhang X, Li T. Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar 20; 44(3):553-562. PubMed ID: 38597447 [Abstract] [Full Text] [Related]
3. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality. Hartman MHT, Eppinga RN, Vlaar PJJ, Lexis CPH, Lipsic E, Haeck JDE, van Veldhuisen DJ, van der Horst ICC, van der Harst P. Clin Cardiol; 2017 May 20; 40(5):322-328. PubMed ID: 28026027 [Abstract] [Full Text] [Related]
5. The predictive value of M30 and oxidative stress for left ventricular remodeling in patients with anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Türkoğlu C, Gür M, Şeker T, Selek Ş, Koçyiğit A. Coron Artery Dis; 2016 Dec 20; 27(8):690-695. PubMed ID: 27479531 [Abstract] [Full Text] [Related]
6. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Ørn S, Ueland T, Manhenke C, Sandanger Ø, Godang K, Yndestad A, Mollnes TE, Dickstein K, Aukrust P. J Intern Med; 2012 Sep 20; 272(3):267-76. PubMed ID: 22243053 [Abstract] [Full Text] [Related]
8. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial). Daaboul Y, Korjian S, Weaver WD, Kloner RA, Giugliano RP, Carr J, Neal BJ, Chi G, Cochet M, Goodell L, Michalak N, Rusowicz-Orazem L, Alkathery T, Allaham H, Routray S, Szlosek D, Jain P, Gibson CM. Am J Cardiol; 2016 Sep 01; 118(5):625-31. PubMed ID: 27392509 [Abstract] [Full Text] [Related]
9. Cardiac magnetic resonance-tissue tracking for the early prediction of adverse left ventricular remodeling after ST-segment elevation myocardial infarction. Cha MJ, Lee JH, Jung HN, Kim Y, Choe YH, Kim SM. Int J Cardiovasc Imaging; 2019 Nov 01; 35(11):2095-2102. PubMed ID: 31267265 [Abstract] [Full Text] [Related]
10. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF. Liu H, Su Y, Shen J, Jiao Y, Li Y, Liu B, Hou X, Jin Q, Chen Y, Sun Z, Xi Q, Feng B, Fu Z. ESC Heart Fail; 2024 Apr 01; 11(2):937-949. PubMed ID: 38224955 [Abstract] [Full Text] [Related]
11. Association between cardiac magnetic resonance ventricular strain and left ventricular thrombus in patients with ST-segment elevation myocardial infarction. Chen Q, Zhang Z, Chen L, Zhou Z, Lu Y, Zhang C, Li C, Zhang Z, Chen W. Int J Cardiovasc Imaging; 2024 Aug 01; 40(8):1735-1744. PubMed ID: 38884697 [Abstract] [Full Text] [Related]
12. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention. Siva Sankara C, Rajasekhar D, Vanajakshamma V, Praveen Kumar BS, Vamsidhar A. Indian Heart J; 2015 Aug 01; 67(4):318-27. PubMed ID: 26304563 [Abstract] [Full Text] [Related]
13. Is cardiac magnetic resonance necessary for prediction of left ventricular remodeling in patients with reperfused ST-segment elevation myocardial infarction? Kim EK, Song YB, Chang SA, Park SJ, Hahn JY, Choi SH, Choi JH, Gwon HC, Park SW, Choe YH, Ahn J, Carriere K, Lee SC. Int J Cardiovasc Imaging; 2017 Dec 01; 33(12):2003-2012. PubMed ID: 28660388 [Abstract] [Full Text] [Related]
14. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. Steen H, Futterer S, Merten C, Jünger C, Katus HA, Giannitsis E. J Cardiovasc Magn Reson; 2007 Dec 01; 9(5):749-58. PubMed ID: 17891611 [Abstract] [Full Text] [Related]
15. Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy). Podlesnikar T, Pizarro G, Fernández-Jiménez R, Montero-Cabezas JM, Greif N, Sánchez-González J, Bucciarelli-Ducci C, Marsan NA, Fras Z, Bax JJ, Fuster V, Ibáñez B, Delgado V. J Cardiovasc Magn Reson; 2020 Jun 11; 22(1):44. PubMed ID: 32522198 [Abstract] [Full Text] [Related]
16. Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance. Bulluck H, Go YY, Crimi G, Ludman AJ, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Pica S, Raineri C, Sirker A, Herrey AS, Manisty C, Groves A, Moon JC, Hausenloy DJ. J Cardiovasc Magn Reson; 2017 Mar 13; 19(1):26. PubMed ID: 28285594 [Abstract] [Full Text] [Related]
17. Utility of CMR Markers of Myocardial Injury in Predicting LV Functional Recovery: Results from PROTECTION AMI CMR Sub-study. Grover S, Bell G, Lincoff M, Jeorg L, Madsen PL, Huang S, Leow S, Figtree G, Chakrabarty A, Leong DP, Woodman RJ, Selvanayagam JB. Heart Lung Circ; 2015 Sep 13; 24(9):891-7. PubMed ID: 25846255 [Abstract] [Full Text] [Related]
18. ST2 and left ventricular remodeling after ST-segment elevation myocardial infarction: A cardiac magnetic resonance study. Miñana G, Núñez J, Bayés-Genís A, Revuelta-López E, Ríos-Navarro C, Núñez E, Chorro FJ, López-Lereu MP, Monmeneu JV, Lupón J, Bodí V. Int J Cardiol; 2018 Nov 01; 270():336-342. PubMed ID: 29954670 [Abstract] [Full Text] [Related]
19. Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function. Fan L, Liu B, Guo R, Luo J, Li H, Li Z, Xu W. Int J Med Sci; 2019 Nov 01; 16(8):1171-1179. PubMed ID: 31523180 [Abstract] [Full Text] [Related]